Machine learning-based identification of novel hub genes associated with oxidative stress in lupus nephritis: implications for diagnosis and therapeutic targetsHuiqiong Zeng, Yu Zhuang, Xiaodong Yan, Xiaoyan He, Qianwen Qiu, Wei Liu, Ye Zhang
18 April 2024
Exacerbating effects of circadian rhythm disruption on the systemic lupus erythematosusLuping Shen, Mo Han, Xuan Luo, Qixiang Zhang, Huanke Xu, Jing Wang, Ning Wei, Qing Liu, Guangji Wang, Fang Zhou
9 April 2024
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysisThunyatorn Wuttiputhanun, Nuanjanthip Naiyarakseree, Suwasin Udomkarnjananun, Wonngarm Kittanamongkolchai, Leelahavanichkul Asada, Pajaree Chariyavilaskul, Natavudh Townamchai, Yingyos Avihingsanon
17 January 2024
Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritisLaura Patricia Whittall-Garcia, Farnoosh Naderinabi, Dafna D Gladman, Murray Urowitz, Zahi Touma, Ana Konvalinka, Joan Wither
4 January 2024
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathyTian Ye, Mengya Jiang, Xueyan Zeng, Dan Zong, Yuanyuan Du, Xiaohong Li, Biao Huang, Xuanli Tang
28 December 2023
Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world dataKaren Worley, Scott Milligan, Bernard Rubin
22 December 2023
Canadian patient experiences of lupus nephritis: a qualitative analysisFrancesca S Cardwell, Susan J Elliott, Megan R W Barber, Kim Cheema, Sydney George, Adrian Boucher, Ann Elaine Clarke
9 December 2023
p16, a marker of cellular senescence, is associated with renal disease in the B6.NZMSle1/Sle2/Sle3 mouse model of lupusGaëlle Tilman, Emilie Dupré, Laura Watteyne, Charlotte Anne Baert, Delphine Nolf, Fatima Benhaddi, Fanny Lambert, Aurélie Daumerie, Caroline Bouzin, Sophie Lucas, Nisha Limaye
29 October 2023
Microvascular C5b-9 deposition in non-lesional skin in patients with SLE and its correlation with active lupus nephritis: a prospective observational studyMeghan Anderson, Cynthia Magro, H Michael Belmont
24 October 2023
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trialDavid Jayne, Brad Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Weifeng Tang, Raj Tummala, Catharina Lindholm
22 August 2023